ASTRAZENECA PLC ORD SHS $0.25 (AZN.L) Financials
AZN.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 7.9 trillion | 4.9 trillion |
2023-09-30 | 7.9 trillion | 4.8 trillion |
2023-06-30 | 7.6 trillion | 4.7 trillion |
2023-03-31 | 7.8 trillion | 4.9 trillion |
AZN.L Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 112.6 billion | ? |
2023-09-30 | 183.2 billion | ? |
2023-06-30 | 97.8 billion | ? |
2023-03-31 | 134.2 billion | ? |
AZN.L Net Income
Date | Net Income |
---|---|
2023-12-31 | 70.4 billion |
2023-09-30 | 135.4 billion |
2023-06-30 | 165.4 billion |
2023-03-31 | 182.6 billion |
AZN.L Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 460.0 billion | - | 88.5 billion |
2023-09-30 | 419.4 billion | - | 80.3 billion |
2023-06-30 | 460.4 billion | - | 75.5 billion |
2023-03-31 | 521.5 billion | - | 77.6 billion |
AZN.L Shares Outstanding
AZN.L Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 74.3 billion | 241.2 billion | 1.1 trillion | 1.4 trillion |
2023-09-30 | 72.1 billion | 211.9 billion | 393.5 billion | 404.1 billion |
2023-06-30 | 38.3 billion | 211.3 billion | 394.9 billion | 405.3 billion |
2023-03-31 | 118.6 billion | 210.7 billion | 327.6 billion | 338.4 billion |
AZN.L Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 943.8 billion | 181.2 billion |
2023-09-30 | 942.2 billion | 171.8 billion |
2023-06-30 | 904.3 billion | 155.3 billion |
2023-03-31 | 878.0 billion | 153.8 billion |
AZN.L
Price: £120.50
Dividend Yield: 0.00%
Forward Dividend Yield: 2.59%
Payout Ratio: 10331.13%
Dividend Per Share: 312.00 GBp
Earnings Per Share: 3.02 GBp
P/E Ratio: 32.32
Exchange: LSE
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 1.8 million
Market Capitalization: 166.4 billion
Average Dividend Frequency: 2
Years Paying Dividends: 32
DGR3: 3.39%
DGR5: 3.58%
DGR10: 3.21%
DGR20: 9.69%